Literature DB >> 17137718

Sepsis and burn complicated by sepsis alter cardiac transporter expression.

Cherry Ballard-Croft1, David L Maass, Patricia J Sikes, Jureta W Horton.   

Abstract

UNLABELLED: Sepsis alone and burn complicated by sepsis produce significant cardiac dysfunction. Since calcium handling by the cardiomyocyte is essential for cardiac function, one mechanism for cardiac abnormalities may be calcium dyshomeostasis. We hypothesized that sepsis and burn plus sepsis alter cardiac calcium transporter expression. Sprague-Dawley rats were divided into: (1) control, (2) sepsis (intratracheal S. Pneumoniae, 4x10(6) CFU), and (3) burn (40% TBSA) plus sepsis. Myocyte [Ca(2+)](i) and [Na(+)](i) were quantified with Fura-2 AM and SBFI, respectively. Western blot analysis of rat hearts used antibodies against the sarcoplasmic reticular Ca(2+) ATPase (SERCA), the L-type calcium channel, the Na(+)/Ca(2+) exchanger or the Na(+)/K(+) ATPase.
RESULTS: Sepsis in the presence and absence of burn trauma increased [Ca(2+)](i) and [Na(+)](i). SERCA expression was decreased in the sepsis and burn plus sepsis groups while calcium channel expression was transiently increased in these sepsis groups. Na(+)/Ca(2+) exchanger expression exhibited a biphasic pattern of altered expression. Sepsis and burn plus sepsis reduced Na(+)/K(+) ATPase protein levels. These data suggest that altered transporter expression produce cardiomyocyte calcium and sodium loading and may contribute to sepsis-mediated cardiac contractile dysfunction.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17137718     DOI: 10.1016/j.burns.2006.06.009

Source DB:  PubMed          Journal:  Burns        ISSN: 0305-4179            Impact factor:   2.744


  5 in total

Review 1.  The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill.

Authors:  O Friedrich; M B Reid; G Van den Berghe; I Vanhorebeek; G Hermans; M M Rich; L Larsson
Journal:  Physiol Rev       Date:  2015-07       Impact factor: 37.312

Review 2.  [Heart in sepsis : Molecular mechanisms, diagnosis and therapy of septic cardiomyopathy].

Authors:  L Martin; M Derwall; C Thiemermann; T Schürholz
Journal:  Anaesthesist       Date:  2017-07       Impact factor: 1.041

Review 3.  Cardiovascular Dysfunction Following Burn Injury: What We Have Learned from Rat and Mouse Models.

Authors:  Ashley N Guillory; Robert P Clayton; David N Herndon; Celeste C Finnerty
Journal:  Int J Mol Sci       Date:  2016-01-02       Impact factor: 5.923

4.  The synthetic antimicrobial peptide 19-2.5 attenuates septic cardiomyopathy and prevents down-regulation of SERCA2 in polymicrobial sepsis.

Authors:  Lukas Martin; Klemens Horst; Fausto Chiazza; Silvia Oggero; Massimo Collino; Klaus Brandenburg; Frank Hildebrand; Gernot Marx; Christoph Thiemermann; Tobias Schuerholz
Journal:  Sci Rep       Date:  2016-11-17       Impact factor: 4.379

5.  Cardioprotective Effect of Tangeretin by Inhibiting PTEN/AKT/mTOR Axis in Experimental Sepsis-Induced Myocardial Dysfunction.

Authors:  Predeepkumar Narayanappa Shiroorkar; Obaid Afzal; Imran Kazmi; Fahad A Al-Abbasi; Abdulmalik Saleh Alfawaz Altamimi; Kumar Shiva Gubbiyappa; Nagaraja Sreeharsha
Journal:  Molecules       Date:  2020-11-29       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.